Knee pain drug trial halted early – what happened?
NCT ID NCT05462990
First seen Feb 02, 2026 · Last updated May 25, 2026 · Updated 13 times
Summary
This study tested an experimental drug called QUC398 in 101 people with painful knee osteoarthritis. The goal was to see if it could reduce pain and protect knee cartilage. The trial was stopped early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOARTHRITIS, KNEE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Boston Univ School of Medicine
Boston, Massachusetts, 02118, United States
-
Clinical Research of West Florida Inc
Tampa, Florida, 33603, United States
-
Novartis Investigative Site
Southport, Queensland, 4222, Australia
-
Novartis Investigative Site
Christchurch, 8011, Australia
-
Novartis Investigative Site
St Leonards, 2065, Australia
-
Novartis Investigative Site
Herlev, 2730, Denmark
-
Novartis Investigative Site
Vejle, 7100, Denmark
-
Novartis Investigative Site
Nice, 06001, France
-
Novartis Investigative Site
Orléans, 45100, France
-
Novartis Investigative Site
Sabadell, Barcelona, 08208, Spain
-
Novartis Investigative Site
Leganés, Madrid, 28915, Spain
-
Novartis Investigative Site
A Coruña, 15006, Spain
-
Novartis Investigative Site
Seville, 41010, Spain
-
West Clinical Research
Morehead City, North Carolina, 28557, United States
Conditions
Explore the condition pages connected to this study.